533 related articles for article (PubMed ID: 27912875)
1. Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial.
Mao JJ; Xie SX; Keefe JR; Soeller I; Li QS; Amsterdam JD
Phytomedicine; 2016 Dec; 23(14):1735-1742. PubMed ID: 27912875
[TBL] [Abstract][Full Text] [Related]
2. Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder.
Keefe JR; Mao JJ; Soeller I; Li QS; Amsterdam JD
Phytomedicine; 2016 Dec; 23(14):1699-1705. PubMed ID: 27912871
[TBL] [Abstract][Full Text] [Related]
3. Putative Antidepressant Effect of Chamomile (
Amsterdam JD; Li QS; Xie SX; Mao JJ
J Altern Complement Med; 2020 Sep; 26(9):813-819. PubMed ID: 31808709
[No Abstract] [Full Text] [Related]
4. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder.
Amsterdam JD; Li Y; Soeller I; Rockwell K; Mao JJ; Shults J
J Clin Psychopharmacol; 2009 Aug; 29(4):378-82. PubMed ID: 19593179
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Chamomile Therapy of Generalized Anxiety Disorder: A Study Protocol for a Randomized, Double-Blind, Placebo- Controlled Trial.
Mao JJ; Li QS; Soeller I; Rockwell K; Xie SX; Amsterdam JD
J Clin Trials; 2014 Nov; 4(5):. PubMed ID: 29057164
[TBL] [Abstract][Full Text] [Related]
6. Specific expectancies are associated with symptomatic outcomes and side effect burden in a trial of chamomile extract for generalized anxiety disorder.
Keefe JR; Amsterdam J; Li QS; Soeller I; DeRubeis R; Mao JJ
J Psychiatr Res; 2017 Jan; 84():90-97. PubMed ID: 27716513
[TBL] [Abstract][Full Text] [Related]
7. Chamomile (Matricaria recutita) may provide antidepressant activity in anxious, depressed humans: an exploratory study.
Amsterdam JD; Shults J; Soeller I; Mao JJ; Rockwell K; Newberg AB
Altern Ther Health Med; 2012; 18(5):44-9. PubMed ID: 22894890
[TBL] [Abstract][Full Text] [Related]
8. An exploratory study of salivary cortisol changes during chamomile extract therapy of moderate to severe generalized anxiety disorder.
Keefe JR; Guo W; Li QS; Amsterdam JD; Mao JJ
J Psychiatr Res; 2018 Jan; 96():189-195. PubMed ID: 29080520
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Matricaria chamomilla (chamomile) extract on pain control of cyclic mastalgia: a double-blind randomised controlled trial.
Saghafi N; Rhkhshandeh H; Pourmoghadam N; Pourali L; Ghazanfarpour M; Behrooznia A; Vafisani F
J Obstet Gynaecol; 2018 Jan; 38(1):81-84. PubMed ID: 29072514
[TBL] [Abstract][Full Text] [Related]
10. Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial.
Savage KM; Stough CK; Byrne GJ; Scholey A; Bousman C; Murphy J; Macdonald P; Suo C; Hughes M; Thomas S; Teschke R; Xing C; Sarris J
Trials; 2015 Nov; 16():493. PubMed ID: 26527536
[TBL] [Abstract][Full Text] [Related]
11. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.
Sarris J; Stough C; Bousman CA; Wahid ZT; Murray G; Teschke R; Savage KM; Dowell A; Ng C; Schweitzer I
J Clin Psychopharmacol; 2013 Oct; 33(5):643-8. PubMed ID: 23635869
[TBL] [Abstract][Full Text] [Related]
12. A pilot randomized double-blind placebo-controlled trial on topical chamomile (Matricaria chamomilla L.) oil for severe carpal tunnel syndrome.
Hashempur MH; Lari ZN; Ghoreishi PS; Daneshfard B; Ghasemi MS; Homayouni K; Zargaran A
Complement Ther Clin Pract; 2015 Nov; 21(4):223-8. PubMed ID: 26573447
[TBL] [Abstract][Full Text] [Related]
13. Generalized anxiety disorder (GAD): efficacy of standardized Matricaria recutita (German chamomile) extract in the treatment of generalized anxiety disorder.
Ross SM
Holist Nurs Pract; 2013; 27(6):366-8. PubMed ID: 24121702
[No Abstract] [Full Text] [Related]
14. Long-term efficacy of pregabalin in generalized anxiety disorder.
Feltner D; Wittchen HU; Kavoussi R; Brock J; Baldinetti F; Pande AC
Int Clin Psychopharmacol; 2008 Jan; 23(1):18-28. PubMed ID: 18090504
[TBL] [Abstract][Full Text] [Related]
15. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
Griebel G; Beeské S; Stahl SM
J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy and safety of chamomile for state anxiety, generalized anxiety disorder, insomnia, and sleep quality: A systematic review and meta-analysis of randomized trials and quasi-randomized trials.
Hieu TH; Dibas M; Surya Dila KA; Sherif NA; Hashmi MU; Mahmoud M; Trang NTT; Abdullah L; Nghia TLB; Y MN; Hirayama K; Huy NT
Phytother Res; 2019 Jun; 33(6):1604-1615. PubMed ID: 31006899
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating Disorder: A Randomized Clinical Trial.
Hudson JI; McElroy SL; Ferreira-Cornwell MC; Radewonuk J; Gasior M
JAMA Psychiatry; 2017 Sep; 74(9):903-910. PubMed ID: 28700805
[TBL] [Abstract][Full Text] [Related]
18. Lu AA21004, a multimodal psychotropic agent, in the prevention of relapse in adult patients with generalized anxiety disorder.
Baldwin DS; Loft H; Florea I
Int Clin Psychopharmacol; 2012 Jul; 27(4):197-207. PubMed ID: 22475889
[TBL] [Abstract][Full Text] [Related]
19. Treatment of anxiety, tension and restlessness states with Kava special extract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trial.
Gastpar M; Klimm HD
Phytomedicine; 2003 Nov; 10(8):631-9. PubMed ID: 14692723
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of topical Matricaria chamomilla L. (chamomile) oil for knee osteoarthritis: A randomized controlled clinical trial.
Shoara R; Hashempur MH; Ashraf A; Salehi A; Dehshahri S; Habibagahi Z
Complement Ther Clin Pract; 2015 Aug; 21(3):181-7. PubMed ID: 26256137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
